Skip to main content
. 2024 Jun 25;18(10):2586–2600. doi: 10.1002/1878-0261.13679

Table 1.

Demographics. Data are represented as N (%). Percentages are calculated in relation to the number of available data.

Endometrioid ovarian carcinoma (N = 86) Serous ovarian carcinoma (N = 582) P‐value (Khi2 or Wilcoxon) Endometrioid ovarian carcinoma FFPE subset (n = 43)
Median age [Min‐Max] 55 [20–88] 61 [18–91] < 0.001 62 [39–88]
FIGO stage
I‐II 37 (49) 89 (16) < 0.001 17 (39)
III‐IV 39 (51) 475 (84) 27 (61)
Grade
Low 24 (53) 43 (29) 0.004 25 (63)
High 21 (47) 106 (71) 15 (37)
Surgical macroscopic resection
Complete 55 (81) 351 (72) 0.172 27 (84)
Incomplete 13 (19) 135 (28) 5 (16)
Adjuvant chemotherapy
Yes 72 (89) 558 (96) 0.006 37 (84)
No 9 (11) 21 (4) 7 (16)